Cell and Gene Therapy World Asia 2025

2025 Speakers

Esteemed voices from the CGT industry across Taiwan, China, Japan, Singapore, India, Australia, South Korea, Indonesia, Thailand, and more, will gather in Singapore in September to share insights on the latest developments in this dynamic field. Speakers include Jimmy Chang (CEO, TaiMed Biologics), Paula Lam (CSO, BioCell Innovations), Richard Wang (Founder & CEO, Neukio Biotherapeutics), Julio Lin (Vice President, Blue Blood Biotech), Rebecca McQualter (CEO, Chimeric Therapeutics), Maloy Ghosh (CSO, Zumutor Biologics), Andrew Bruce (CEO, Medisix Therapeutics), Jennifer Kuan (VP of Taiwan Operations, Bora Biologics), and Ivan Horak (Founder & CEO, Tikva Allocell).

CAR-T advancements

CAR-T cell therapy will be a key focus at the 9th Annual Cell and Gene Therapy World Asia 2025, reflecting its growing clinical and commercial relevance across the region. The agenda includes in-depth discussions on CAR-T development, manufacturing, and clinical translation. Attendees can expect insights into the evolving CAR-T landscape in Asia, including case studies and regional trial experiences. With participation from leading organizations such as Legend Biotech and SCG Cell Therapy, both active in CAR-T innovation, the conference offers a platform for stakeholders to exchange knowledge and explore collaborative opportunities.

Sessions include ‘The Revolution of CAR-T Therapy: Current Frontiers and Future Horizons’, in which an expert panel of leaders will discuss the latest advancements in CAR-T engineering to improve efficacy and safety, as well as how regional collaborations can accelerate market access. Tools and technologies to enable CAR-T manufacturing will also be explored, in the sessions ‘Revolutionizing CAR-T Production: The Role of Automation’ and ‘AI and Next-Generation Bioreactors for Scalable CAR-T Manufacturing’.

Vector manufacturing strategies

Vector manufacturing will be another critical theme at Cell and Gene Therapy World Asia 2025, addressing one of the most pressing challenges in the cell and gene therapy pipeline. The agenda includes focused sessions on upstream processing and vector design, in addition to innovations in vector analytics and characterization services. As the APAC region continues to expand its footprint in gene therapy, these sessions will provide a timely platform for knowledge exchange in advancing vector manufacturing capabilities.

On the agenda, a presentation entitled ‘Scalable Production Solutions for AAV Vector Manufacturing’ will explore suspension-based bioreactor systems for improved scalability and reduced production costs, in addition to the benefits of templated platforms for AAV production. ‘Advancements in Bacterial and Viral Vector Platforms for Gene Therapy’ will explore the potential of bacterial vectors as alternatives to viral-based systems, as well as current innovations in improving the safety profile and therapeutic efficiency of viral vectors like AAV and lentivirus.

Commercialization

With the Asia-Pacific CGT market projected to reach US$4 billion by 2027, the region’s growing role in translating advanced therapies from bench to market will also be explored. Discussions will cover critical enablers such as cryogenic logistics, supply chain management, and regional regulatory harmonization. Sessions, such as ‘Digital Transformation in CGT Supply Chains’, will highlight case studies from emerging biotech hubs such as China, India, and Southeast Asia, offering insights into successful commercialization pathways.

The closing plenary session, ‘Charting the Next Decade: Transforming Cell and Gene Therapy in Asia’, will explore the most critical investments needed to advance manufacturing and infrastructure capabilities in the region, in addition to achieving regulatory harmonization across Asia to accelerate approvals.

As a reader of Cell & Gene Therapy Insights, you’re entitled to a 15% discount on delegate tickets—just use the code BIOINSIGHTS. You can find out more about Cell and Gene Therapy World Asia 2025 here.

Additionally, to find out what other cell and gene therapy events are upcoming, you can find our online Events Calendar here.